» Articles » PMID: 31304415

Bioactive Fluorenes. Part I. Synthesis, Pharmacological Study and Molecular Docking of Novel Dihydrofolate Reductase Inhibitors Based-2,7-dichlorofluorene

Overview
Journal Heliyon
Specialty Social Sciences
Date 2019 Jul 16
PMID 31304415
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, a new series of 2,7-dichloro-4-(2-substituted-amino acetyl)fluorene derivatives were synthesized, characterized and evaluated for their antimicrobial activity and screened for cytotoxic activity against human lung carcinoma (A-549) and human breast carcinoma (MCF-7) cell lines. Most of the synthesized compounds displayed significant activity against A-549 and MCF-7 cell lines when compared to 5-fluorouracil (5-FU), which was used as a reference drug. In addition, some of these reported novel compounds exhibited promising antibacterial and antifungal properties. A molecular docking study was performed to identify the mechanism of action of the synthesized compounds, which suggested binding interactions with the active sites of dihydrofolate reductase (DHFR).

Citing Articles

An Intervention into the Diverse Utilities of Fluorenes: A Brobdingnagian Family.

Sreekumar A, Nair A, Raksha C, Swayamprabha S, Sivan A Top Curr Chem (Cham). 2024; 383(1):4.

PMID: 39680345 DOI: 10.1007/s41061-024-00485-6.


Design, synthesis, molecular docking, and dynamics studies of novel thiazole-Schiff base derivatives containing a fluorene moiety and the assessment of their antimicrobial and antioxidant activity.

Marufa S, Rahman T, Rahman M, Rahman M, Khan S, Jahan R RSC Adv. 2024; 14(47):35198-35214.

PMID: 39497776 PMC: 11533417. DOI: 10.1039/d4ra04197f.


Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell Lines.

Galassi R, Sargentoni N, Renzi S, Luciani L, Bartolacci C, Pattabhi P Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338298 PMC: 11435220. DOI: 10.3390/ph17091133.


Synthesis of Triarylmethanes via Palladium-Catalyzed Suzuki-Miyaura Reactions of Diarylmethyl Esters.

Dardir A, Casademont-Reig I, Balcells D, Ellefsen J, Espinosa M, Hazari N Organometallics. 2022; 40(14):2332-2344.

PMID: 35719693 PMC: 9199486. DOI: 10.1021/acs.organomet.1c00085.


Preparative Production of Functionalized (- and -Heterocyclic) Polycyclic Aromatic Hydrocarbons by Human Cytochrome P450 3A4 in a Bioreactor.

Srdic M, Fessner N, Yildiz D, Glieder A, Spiertz M, Schwaneberg U Biomolecules. 2022; 12(2).

PMID: 35204652 PMC: 8961652. DOI: 10.3390/biom12020153.


References
1.
Brown K, KRAUT J . Exploring the molecular mechanism of dihydrofolate reductase. Faraday Discuss. 1992; (93):217-24. DOI: 10.1039/fd9929300217. View

2.
Zhang X, Wang J, Su M, Li Z, Li J, Li J . Discovering novel α-aminoacyl-containing proline derivatives with potent and selective inhibitory activity against dipeptidyl peptidase IV: design, synthesis, biological evaluation, and molecular modeling. Chem Biol Drug Des. 2012; 80(6):843-52. DOI: 10.1111/j.1747-0285.2012.01438.x. View

3.
Azuma T, Saita T, Isono K . Polyoxin analogs. III. Synthesis and biological activity of aminoacyl derivatives of polyoxins C and L. Chem Pharm Bull (Tokyo). 1977; 25(7):1740-8. DOI: 10.1248/cpb.25.1740. View

4.
Hawser S, Lociuro S, Islam K . Dihydrofolate reductase inhibitors as antibacterial agents. Biochem Pharmacol. 2005; 71(7):941-8. DOI: 10.1016/j.bcp.2005.10.052. View

5.
Jo J, Chi C, Hoger S, Wegner G, Yoon D . Synthesis and characterization of monodisperse oligofluorenes. Chemistry. 2004; 10(11):2681-8. DOI: 10.1002/chem.200305659. View